Apella Capital’s HOOKIPA Pharma HOOK Stock Holding History

Apella Capital’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,978	Closed	-$16.6K	–	315
2024 Q1	$16.6K	Hold	1,978	–	–	﹤0.01%	293
2023 Q4	$14.9K	Buy	+1,978	New	+$10.9K	﹤0.01%	292

Other funds holding HOOK

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Apella Capital's HOOK Position: Q2 2024 in Review

Apella Capital sold out of HOOKIPA Pharma (HOOK) in Q2 2024, closing a stake of 1,978 shares — an estimated $16.6K sold.

Apella Capital first reported a position in HOOK in Q4 2023 and held it in 2 quarters. The position peaked at $16.6K in Q1 2024. 40 funds tracked by Wall St. Rank hold HOOK as of Q2 2024.

Apella Capital reported no remaining HOOKIPA Pharma position as of Q2 2024 after selling out during the quarter.
Apella Capital sold 1,978 HOOKIPA Pharma shares in Q2 2024, an estimated $16.6K.
Apella Capital first reported a position in HOOKIPA Pharma in Q4 2023 and held it in 2 quarters.
Apella Capital's HOOKIPA Pharma position peaked at $16.6K in Q1 2024.
40 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2024.

Based on Apella Capital's 13F filing for Q2 2024, filed 10 Jul 2024.